PPMI. PPMI defined as 3-fold increase in CK-MB or troponin-I after procedure and patients initially diagnosed with MI excluded. Results: In multivariate analysis, the independent predictors for PPMI after bifurcation stenting were acute closure in side branch, unstable angina, more than 30mm in total stent length of parent vessel (PV), left main or 3 vessel disease, and Taxus® in PV (HR=4.177; 95% CI=1. HR=2.283;; HR=1.035; 95% CI=1.014-1.057, HR=1.759; 95% CI=1.220-2.535 and HR=1.717; 95% CI=1.194-2.468 respectively). During 22-month follow-up, there was no difference in mortality between PPMI and no PPMI group (96.3% vs. 98.7%, p=0.168). Propensity scoreadjusted Cox regression analysis showed that the PPMI was not an independent predictor of mortality (adjusted HR 0.749; p=0.777).
Background:
The provisional approach has become the default strategy in bifurcation PCI. However, there are some inherent limitations of the provisional approach including the acceptance of a suboptimal result at the side branch (SB) and the risk of SB compromise or even occlusion. A dedicated SB stent may overcome some of these limitations of provisional stenting by facilitating the procedure. However, there are limited data to support this approach Methods: We performed a retrospective cross-sectional survey of the current practice of provsional stenting for the bifurcation. The survey collected procedural data of 110 bifurcations most recently treated with a provsional approach in 4 centres. We then compared these data with patients enrolled in the multi-centre European registry of true bifurcations treated with Sideguard (Cappella Inc., Galway, Ireland) dedicated side branch stent. The primary endpoint of the study was SB failure defined as: residual SB stenosis≥50%; inability to re-access the SB after main branch (MB) treatment; dissection of the SB; and need for cross-over to SB stenting. Results: Almost all lesions treated were true bifurcations in both the provisional and Sideguard groups (97% vs. 96%). Procedural success was high in both groups (97% vs. 96%). In the provisional group, the SB was stented in 15% of cases and 22% had a SB residual stenosis≥50% at the end of the procedure. The primary endpoint of SB failure occurred significantly more frequently in the provisional group (33% vs. 5%; p=0.01). Procedural (78±23 vs. 67±29 mins; p=NS) and flouroscopy time (21.2±8.9 vs. 22+/-5.5; p=NS) were similar in both groups. Conclusion: SB ostial protection with the Sideguard device reduces SB failure in comparison to provisional stenting without increasing procedural time. The Sideguard dedicated bifurcation stent could facilitate bifurcation PCI and make the procedure more predictable and safe. This approach requires further evaluation in a randomized controlled trial. Background: Provisional stenting is now the default approach for treatment of bifurcation lesions. It is however still controversial whether dilatation of the Side Branch (SB) after Main Vessel (MV) stenting is beneficial and when Kissing Balloon (KB) inflation should be performed. Methods: Optimisation using final KB technique was compared with a simpler sequential 2 step SB-MV dilatation without kiss in a series of drug eluting stents (n=26) delivered in a bench model of a representative coronary bifurcation. Stent apposition and stent area was quantified at different locations along the MV from micro-CT scans. Vessel wall stresses and detailed reconstruction of blood flow patterns were obtained in the model using Finite Element Analysis (FEA) and Computational Fluid Dynamics (CFD). Results: SB ostial stenosis was on average 20.9 ± 8.7 % after KB and 25.6 ± 11.6 % after 2-Step sequential optimization (p=0.25, ns) compared to 69.2 ± 7.8 % without SB dilatation, p<0.0001. Differences were observed between the stent platforms with CoCr and PtCr stents producing higher ostial stenosis than SS based platforms (respectively 27.3 ± 8.5% and 20.0 ± 10.2%, p=0.06). KB induced a significant asymmetric expansion of the lumen proximal to the SB and led to a higher risk of incomplete stent apposition at the proximal stent edge (36.4 ± 29.8 % vs. 3.8 ± 10.1 % for 2-step, p=0.0016). SB dilatation alone without further MV post-dilatation is associated distortion of the stent at the MV ostium, resulting in a high risk of stent malapposition opposite the SB. Rate of malapposition in the bifurcation after KB and 2-Step was respectively 22.1 ± 8.9 % and 26.6 ± 8.9 %, a significant reduction compared to SB dilatation (55.3 ± 16.8 %, p<0.0001) or MV stenting only (47.0 ± 8.5 %, p<0.0005). Conclusion: Sequential 2-step post-dilatation of the SB and MV may be a suitable alternative to final Kissing Balloon Inflation after provisional stenting of bifurcations. Background: Coronary bifurcation percutaneous treatment represents a special coronary artery disease subset. Various techniques are been used treating these lesions, but few data are available regarding "true" bifurcation lesions (Medina 1,1,1) . Methods: We evaluated major adverse cardiovascular events (MACE) trend in a nation-wide retrospective registry of patients that underwent coronary bifurcation percutaneous treatment, comparing provisional stenting technique versus both branches PCI. Results: We enrolled 2447 patients, with a mean follow up of 32 months (±16). 1271 were assigned to provisional group (PG, 52% of cases) and both branches PCI (BB). Mean age was 64 years ±12 (p=0,7), LVEF 53% (p=0,4), diabetes was present in 38% and 35% (p=0,4), chronic kidney disease in 9,7% (p=0,6). Multivessel disease interested 39% and 36% (p=0,3) of patients. 4,6% of PCI were performed due bifurcation restenosis in PG instead 7,6% in BB group (p=0,002). 17% of PG patients underwent PCI due acute coronary syndrome in front of 11% of BB patients (p<0,001). Double antiplatelet therapy duration was significantly shorter in PG (8,5 months vs 11, p<0,001) and DES usage was less represented (37% vs 43%, p<0,001). Stent thrombosis was equally represented in the two groups (1,5% vs 2,8%, p=0,3). At univariate analysis, PG is related to better survival free from MACE (p<0,002) and similar overall survival (p=0,8). At Cox regression, DES usage is independently related to greater free from mace survival (95% CI HR 0,6-0,9, p=0,04). On other hand, restenosis as indication for PCI is a MACE predictor (95% CI HR 1,6-2,8, p<0,001). In this setting, no differences are detected between provisional stenting and both branches PCI. Conclusion: Despite the complex lesion subset of true bifurcations, single stent use (provisional approach) is related to better results in term of TLR and MACE, with similar overall survival at middle term follow up, even after double antiplatelet per protocol discontinuation.
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